This may include: Physical examination Blood tests ECG or metabolic testing Detailed informed consent Participants who meet all criteria may then be formally enrolled
Type 2 diabetes mellitus is the dominant segment of the oral GLP-1 agonists market, driven by the worldwide prevalence of the disease and the demand for effective long term glucose management therapies
The mechanisms underlying taste perception changes during GLP-1 therapy are likely multifactorial and indirect rather than representing true gustatory dysfunction
If your insurance does not cover weight loss medications, or you prefer to skip the insurance process entirely, we offer two self-pay options at our Spring Branch clinic: Not sure which option fits your situation
ALCAR is free of sugar, starch, and fillers, making it suitable for horses with insulin resistance, equine metabolic syndrome (EMS), laminitis, or PPID